Stocks · Health care · Pharmaceutical Preparations

Altimmune, Inc.

ALT Clue Score41
United States Fiscal year ends December CIK 0001326190 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
David Drutz
18 Nov 2022
Director
Exercised, kept
139
$2.40
$333.60
Klaus Schafer
20 Jun 2022
Director
Exercised, kept
60
$2.40
$144.00
Klaus Schafer
20 Jun 2022
Director
Exercised, kept
159
$2.40
$381.60
Klaus Schafer
20 Jun 2022
Director
Exercised, kept
60
$2.40
$144.00
David Drutz
25 Jan 2022
Director
Exercised, kept
70
$2.40
$168.00
David Drutz
14 Dec 2021
Director
Exercised, kept
139
$2.40
$333.60
David Drutz
19 Nov 2021
Director
Exercised, kept
70
$2.40
$168.00
David Drutz
13 Nov 2020
Director
Exercised, kept
60
$2.40
$144.00
M Scot Roberts
21 May 2018
Chief Scientific Officer
Exercised, kept
55,120
$0.08
$4.41K
William Enright
2 Jan 2018
President and CEO
Exercised, kept
183,347
$0.08
$14.67K
William Enright
16 Aug 2017
President and CEO
Exercised, kept
91,733
$0.08
$7.34K
William Enright
16 Aug 2017
President and CEO
Exercised, kept
71,644
$0.08
$5.73K
Jeffrey W. Runge
20 Jan 2017
Director
Exercised, kept
20,000
$3.11
$62.20K
Derace L Schaffer
13 Jan 2017
Director
Exercised, kept
20,000
$2.20
$44.00K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
20,000
$2.20
$44.00K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
20,000
$3.11
$62.20K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
20,000
$2.47
$49.40K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
10,000
$2.59
$25.90K
Philip Macneill
21 Dec 2016
VP, CFO, Treasurer, Secretary
Exercised, kept
17,657
$1.66
$29.31K
Philip Macneill
21 Dec 2016
VP, CFO, Treasurer, Secretary
Exercised, kept
5,000
$1.71
$8.55K
Jeffrey W. Runge
28 Nov 2016
Director
Exercised, kept
20,000
$2.20
$44.00K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
20,000
$2.20
$44.00K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
20,000
$1.69
$33.80K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
135,660
$1.71
$231.98K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
240,000
$1.94
$465.60K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
37,500
$1.19
$44.63K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
30,573
$2.46
$75.21K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$2.20
$44.00K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.69
$33.80K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
18,361
$1.81
$33.23K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.51
$30.20K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.64
$32.80K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.45
$29.00K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
52,139
$2.67
$139.21K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
60,000
$2.67
$160.20K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.60
$32.00K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.52
$30.40K
John Gill
22 Nov 2016
President and CEO
Exercised, kept
100,000
$2.20
$220.00K

What was left out

Form 4 filings counted 335
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 13,705,868
Sales filed before the plan box existed 14
History held since 7 May 2007